Literature DB >> 15558238

Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures.

Anna M Oleksik1, Susan Ewing, Wei Shen, Natasja M van Schoor, Paul Lips.   

Abstract

Vertebral fractures are a common complication of osteoporosis and may cause a decrease of health-related quality of life (HRQOL). This study was designed to determine the impact of incident vertebral fractures on HRQOL. The Multiple Outcomes of Raloxifene Evaluation (MORE), a multicenter, randomized, double blind trial, in which women were taking raloxifene or placebo. This study was done in European centers only in a subset of 361 women from seven European countries, all with prevalent vertebral fractures. A specific questionnaire for osteoporosis developed by the International Osteoporosis Foundation was used for assessment at baseline, 1, 2 and 3 years. This questionnaire, Qualeffo, contains 41 questions in the domains pain, physical function, social function, general health perception and mental function. Domain and total scores are expressed on a 100-point scale with 0 corresponding to the best HRQOL. Standardized lateral spinal radiographs were made at baseline, 2 and 3 years and evaluated in a central facility. Sixty-seven patients sustained a fracture in a vertebra that was not fractured at baseline (incident vertebral fractures). Twenty of these were accompanied by signs and symptoms necessitating immediate doctor's attention (clinical vertebral fractures) and 47 vertebral fractures were only diagnosed on radiographs (subclinical vertebral fractures). Incident vertebral fractures (clinical and subclinical) were associated with an increase of back pain (mean score change 6.4; 95% CI 2.1-10.7), deterioration of physical function (mean score change 2.4; 95% CI 0.1-4.8), and worse general health perception (mean score change 3.8; 95% CI 0.1-7.5). Score changes for patients with subclinical vertebral fractures were intermediate between those for patients with clinical vertebral fractures and patients without incident vertebral fracture. Clinical and subclinical incident vertebral fractures both have an adverse impact on HRQOL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558238     DOI: 10.1007/s00198-004-1774-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  47 in total

1.  Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; C D Naylor; E Juniper; D K Heyland; R Jaeschke; D J Cook
Journal:  JAMA       Date:  1997-04-16       Impact factor: 56.272

2.  Stopping the "silent thief".

Authors:  R A Fitzpatrick; R Shorenstein
Journal:  J Am Med Womens Assoc (1972)       Date:  1990 May-Jun

3.  [Burden of illness in vertebral deformities. EVOS group in Germany].

Authors:  C Matthis; H Raspe
Journal:  Med Klin (Munich)       Date:  1998-03-15

Review 4.  Clinical consequences of vertebral fractures.

Authors:  P D Ross
Journal:  Am J Med       Date:  1997-08-18       Impact factor: 4.965

5.  A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture.

Authors:  S E Hall; R A Criddle; T L Comito; R L Prince
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

Review 6.  The clinical impact of vertebral fractures: quality of life in women with osteoporosis.

Authors:  D T Gold
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

Review 7.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

8.  Bone mineral density and depression: a community study in women.

Authors:  R Coelho; C Silva; A Maia; J Prata; H Barros
Journal:  J Psychosom Res       Date:  1999-01       Impact factor: 3.006

9.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

10.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

View more
  44 in total

Review 1.  The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis.

Authors:  A M Briggs; A M Greig; J D Wark
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

2.  Cross-cultural adaptation and validation of the osteoporosis assessment questionnaire short version (OPAQ-SV) for Chinese osteoporotic fracture females.

Authors:  Yin-Ping Zhang; Huan-Huan Wei; Wen Wang; Ru-Yi Xia; Xiao-Ling Zhou; Caroline Porr; Mikko Lammi
Journal:  Clin Rheumatol       Date:  2015-07-15       Impact factor: 2.980

3.  A striving for independence: a qualitative study of women living with vertebral fracture.

Authors:  Inger Hallberg; Anna-Christina Ek; Göran Toss; Margareta Bachrach-Lindström
Journal:  BMC Nurs       Date:  2010-04-16

4.  Medical treatment of osteoporotic vertebral fractures.

Authors:  Bente Lomholt Langdahl; Torben Harsløf
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 5.  Review of radiological scoring methods of osteoporotic vertebral fractures for clinical and research settings.

Authors:  Ling Oei; Fernando Rivadeneira; Felisia Ly; Stephan J Breda; M Carola Zillikens; Albert Hofman; André G Uitterlinden; Gabriel P Krestin; Edwin H G Oei
Journal:  Eur Radiol       Date:  2012-08-15       Impact factor: 5.315

6.  Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis.

Authors:  P Marquis; C Roux; C de la Loge; M Diaz-Curiel; C Cormier; G Isaia; J Badurski; J Wark; P J Meunier
Journal:  Osteoporos Int       Date:  2007-10-11       Impact factor: 4.507

7.  Validation of the Portuguese version of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-41) in Brazilian women with postmenopausal osteoporosis with vertebral fracture.

Authors:  Néville de Oliveira Ferreira; Michael Arthuso; Raimunda Beserra da Silva; Aarão Mendes Pinto-Neto; Lúcia Costa-Paiva
Journal:  Clin Rheumatol       Date:  2013-04-23       Impact factor: 2.980

8.  Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).

Authors:  C Cooper; F Jakob; C Chinn; E Martin-Mola; P Fardellone; S Adami; N C Thalassinos; J Melo-Gomes; D Torgerson; A Gibson; F Marin
Journal:  Osteoporos Int       Date:  2007-10-30       Impact factor: 4.507

9.  Health-related quality of life after vertebral or hip fracture: a seven-year follow-up study.

Authors:  Inger Hallberg; Margareta Bachrach-Lindström; Staffan Hammerby; Göran Toss; Anna-Christina Ek
Journal:  BMC Musculoskelet Disord       Date:  2009-11-03       Impact factor: 2.362

10.  Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.

Authors:  P J Meunier; C Roux; S Ortolani; M Diaz-Curiel; J Compston; P Marquis; C Cormier; G Isaia; J Badurski; J D Wark; J Collette; J Y Reginster
Journal:  Osteoporos Int       Date:  2009-01-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.